<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=BAALC</id>
	<title>BAALC - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=BAALC"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=BAALC&amp;action=history"/>
	<updated>2026-06-18T17:57:59Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=BAALC&amp;diff=5966&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «Brain and acute leukemia cytoplasmic protein  ==Publications==  {{medline-entry |title=Relation of BAALC and ERG Gene Expression with Overall Survival in...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=BAALC&amp;diff=5966&amp;oldid=prev"/>
		<updated>2021-05-12T15:02:56Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «Brain and acute leukemia cytoplasmic protein  ==Publications==  {{medline-entry |title=Relation of &lt;a href=&quot;/BAALC&quot; title=&quot;BAALC&quot;&gt;BAALC&lt;/a&gt; and &lt;a href=&quot;/ERG&quot; title=&quot;ERG&quot;&gt;ERG&lt;/a&gt; Gene Expression with Overall Survival in...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Brain and acute leukemia cytoplasmic protein&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=Relation of [[BAALC]] and [[ERG]] Gene Expression with Overall Survival in Acute Myeloid Leukemia Cases.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26625814&lt;br /&gt;
|abstract=The objectives of this study were to evaluate the expression of brain and acute leukemia, cytoplasmic ([[BAALC]]) gene and erythroblast transformation-specific related gene ([[ERG]]) in de novo cases of acute myeloid leukemia (AML) and identify roles in disease progression and outcome. This study included 50 newly diagnosed AML patients, along with 10 apparently healthy normal controls. [[BAALC]] and [[ERG]] expression was detected in the bone marrow of both patients and controls using real-time RT-PCR. [[BAALC]] and [[ERG]] expression was detected in 52% of cases but not in any controls. There was a statistically significant correlation between [[BAALC]] and [[ERG]] gene expression and age (p- value=0.004 and 0.019, respectively). No statistical significance was noted for sex, lymphadenopathy, hepatomegaly, splenomegaly, other hematological findings, immunophenotyping and FAB sub-classification except for [[ERG]] gene and FAB (p-value=0.058). A statistical significant correlation was found between response to treatment with [[ERG]] expression (p-value=0.028) and age (p-value=0.014). A statistically significant variation in overall survival was evident with patient age, BM blast cells, FAB subgroups, [[BAALC]] and [[ERG]] expression (p-value= &amp;lt;0.001, 0.045, 0.041, &amp;lt;0.008 and 0.025 respectively). Our results suggest that [[BAALC]] and [[ERG]] genes are specific significant molecular markers in AML disease progression, response to treatment and survival.&lt;br /&gt;
|mesh-terms=* Adult&lt;br /&gt;
* Aging&lt;br /&gt;
* Biomarkers, Tumor&lt;br /&gt;
* Bone Marrow&lt;br /&gt;
* Bone Marrow Cells&lt;br /&gt;
* Disease Progression&lt;br /&gt;
* Egypt&lt;br /&gt;
* Female&lt;br /&gt;
* Gene Expression Profiling&lt;br /&gt;
* Humans&lt;br /&gt;
* Leukemia, Myeloid, Acute&lt;br /&gt;
* Male&lt;br /&gt;
* Middle Aged&lt;br /&gt;
* Neoplasm Proteins&lt;br /&gt;
* Trans-Activators&lt;br /&gt;
* Transcriptional Regulator ERG&lt;br /&gt;
* Treatment Outcome&lt;br /&gt;
&lt;br /&gt;
|full-text-url=https://sci-hub.do/10.7314/apjcp.2015.16.17.7875&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>